期刊文献+

终末期肾病维持性血液透析患者cTnT、BNP水平检测及其预后分析 被引量:4

Detection of cTnT and BNP Levels and Analysis of Prognosis in Patients with Maintenance Hemodialysis of End-stage Renal Disease
暂未订购
导出
摘要 目的探讨终末期肾病维持性血液透析患者血清肌钙蛋白(cTnT)、B型钠尿肽(BNP)水平检测与其预后的关系,为患者的临床诊治提供理论依据。方法选取2018年1月-2019年1月在上海曲阳医院就诊的维持性血液透析患者41例为观察组,选取非透析终末期肾病患者41例为对照组。记录两组患者cTnT、BNP超声心动图异常变化情况,比较两组患者死亡发生率及临床资料,分析探讨维持性血液透析患者cTnT、BNP水平检测及其预后的关系。结果观察组患者的收缩压、血肌酐/尿素氮水平均明显高于对照组,差异有统计学意义(P<0.05)。cTnT阴性组患者的超声心动图检测异常发生率(23.52%)明显低于cTnT阳性组患者(58.33%),差异有统计学意义,BNP阴性组患者的超声心动图检测异常发生率(27.78%)明显低于BNP阳性组患者(60.87%),差异有统计学意义(P<0.05)。cTnT阴性组患者的死亡率(11.76%)明显低于cTnT阳性组患者(41.67%),BNP阴性组患者的死亡率(16.67%)明显低于BNP阳性组患者(47.83%),差异有统计学意义(P<0.05)。相关性分析发现,cTnT、BNP水平与患者的预后呈正相关。结论 cTnT、BNP水平与患者的预后呈正相关,上述两种指标的检测能有效改善终末期肾病维持性血液透析患者的预后,降低其病死率,值得临床中用于患者生存的评估。 OBJECTIVE To investigate the relationship between serum troponin(cTnT)and B-type natriuretic peptide(BNP)levels and prognosis in patients with end-stage renal disease maintenance hemodialysis,to provide theoretical basis for the clinical diagnosis and treatment of patients. METHODS 41 patients with maintenance hemodialysis patients who were admitted to target hospital from January 2018 to January 2019 were selected as observation groups, 41 patients with non dialysis end-stage renal disease were selected as the control group. The changes of cTnT and BNP echocardiographic abnormalities in the two groups were recorded, the mortality rate and clinical data of the two groups were compared, and the relationship between cTnT, BNP levels and prognosis in maintenance hemodialysis patients were analyzed. RESULTS The systolic blood pressure and serum creatinine urea nitrogen level in the observation group,were significantly higher than the control group, the difference was statistically significant(P<0.05). The incidence of abnormal echocardiographic detection in cTnT negative group(23.52%)was significantly lower than that in cTnT positive group(58.33%),the difference was statistically significant(P<0.05). The incidence of abnormal echocardiographic detection in BNP negative group(27.78%)was significantly lower than BNP positive group(60.87%), the difference was statistically significant(P<0.05). The mortality rate of cTnT negative group(11.76%)was significantly lower than that of cTnT positive group(41.67%), and the mortality rate of BNP negative group(16.67%)was significantly lower than BNP positive group(47.83%), the difference was statistically significant(P<0.05). The correlation analysis showed that cTnT and BNP levels were positively correlated with the prognosis. CONCLUSION The levels of cTnT and BNP were positively correlated with the prognosis of patients, the detection of these two indicators culd effectively improve the prognosis of patients with end-stage renal disease undergoing maintenance hemodialysis.reduce the mortality rate,whit was worthy of clinical evaluation for patient survival.
作者 刘玲 朱济众 LIU Ling;ZHU ji-zhong
机构地区 上海曲阳医院
出处 《中国初级卫生保健》 2020年第2期97-99,共3页 Chinese Primary Health Care
关键词 终末期肾病 维持性血液透析 CTNT BNP 死亡率 end stage renal disease maintenance hemodialysis cTnT BNP mortality
  • 相关文献

参考文献8

二级参考文献53

  • 1余金波,邹建洲,刘中华,沈波,徐少伟,滕杰,丁小强.维持性血液透析患者透析中低血压的危险因素研究[J].中国血液净化,2012,11(4):189-193. 被引量:63
  • 2陈江华.提高血液透析患者长期生存率所面临的挑战[J].中华肾脏病杂志,2006,22(3):133-134. 被引量:82
  • 3陈献广,吴华,毛永辉,王梅.维持性血液透析患者血清心肌肌钙蛋白T和C反应蛋白水平与预后的关系[J].中华肾脏病杂志,2006,22(3):161-165. 被引量:14
  • 4Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods[ J]. Scand J Clin Invest Suppl, 1999,230(2 ) : 128-131.
  • 5Katus HA, Remppis A, Scheffold T, et al. Intracellu- lar compart- mentation of cardiac troponin T and its release kinetics in patients with reperfused and non- reperfused myocardial infarction [J]. Am J Cardiol, 1991,67: 13604367.
  • 6de Lemos JA, Drazner MH, Omland T, etal. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the gener- al population [J]. JAMA, 2010, 304:2503-2512.
  • 7Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic pep- tide levels and the risk of cardiovascular events and death [J]. N Engl J med, 2004,350:655-663.
  • 8Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuret- ic peptides for community screening for left ventricu- far hypertrophy and systolic dysfunction:the Framing- ham heart study [J]. JAMA, 2002,288:1252-1266.
  • 9Miller WL, Hatman KA, Burritt MF. Serial biomarker mea- surements in ambulatory patients with chronic heart failure : the importance of change over time [J] .Circulation, 2007, 116:249-257.
  • 10Ishii J, Nomura M, Nakamura Y, et al. Risk stratifica- tion using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure [J] . Am J Cardi- ol, 2002,89:691-695.

共引文献76

同被引文献35

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部